Here's the live share price of Cipla along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Cipla | -4.52 | -5.60 | -8.39 | 11.78 | -11.98 | 4.10 | 6.84 |
| Sun Pharmaceutical Industries | -3.86 | -7.81 | -4.78 | 5.15 | 9.05 | 15.99 | 16.46 |
| Divi's Laboratories | -4.13 | -0.21 | 38.04 | 57.30 | 57.03 | 35.28 | 12.03 |
| Torrent Pharmaceuticals | -4.61 | -4.98 | 1.98 | 19.20 | 35.32 | 36.24 | 24.92 |
| Zydus Lifesciences | -5.28 | -1.10 | 3.53 | 31.73 | 15.15 | 23.09 | 15.15 |
| Laurus Labs | -1.85 | 5.42 | 28.77 | 88.09 | 126.67 | 70.34 | 25.88 |
| Mankind Pharma | 0.18 | 4.20 | -0.30 | 24.16 | 1.26 | 11.29 | 11.73 |
| Dr. Reddy's Laboratories | 0.43 | 4.05 | -10.27 | -0.79 | -3.21 | 3.42 | 3.67 |
| Aurobindo Pharma | -2.41 | 0.83 | 7.05 | 25.00 | 52.71 | 22.51 | 17.93 |
| Lupin | -3.83 | -6.62 | -16.20 | -11.72 | 1.93 | 19.65 | 15.89 |
| Glenmark Pharmaceuticals | -4.26 | -6.94 | 3.95 | 8.94 | 15.30 | 39.37 | 34.43 |
| Alkem Laboratories | -1.61 | -0.48 | -5.66 | -1.37 | -4.59 | 13.22 | 5.49 |
| Biocon | -2.95 | -7.86 | -11.73 | 4.88 | 5.01 | 10.70 | 0.27 |
| Abbott India | -2.18 | 1.24 | 2.44 | 0.28 | -12.01 | 4.53 | 2.63 |
| Ipca Laboratories | -2.04 | -1.38 | 12.28 | 29.84 | 46.95 | 27.30 | 9.94 |
| Gland Pharma | 0.05 | 1.81 | 19.28 | 72.61 | 49.39 | 20.02 | -5.49 |
| Anthem Biosciences | -2.76 | -8.95 | 10.24 | 28.59 | 11.99 | 5.20 | 3.09 |
| GlaxoSmithKline Pharmaceuticals | -2.93 | -7.21 | 13.17 | 18.34 | -0.03 | 20.30 | 12.77 |
| Ajanta Pharma | -1.77 | 0.14 | 4.25 | 24.71 | 45.08 | 24.89 | 17.85 |
| Emcure Pharmaceuticals | -0.42 | 4.29 | 4.45 | 25.11 | 44.52 | 12.54 | 7.35 |
Source: Dion Global
Over the last one year, Cipla has declined 11.98% compared to peers like Sun Pharmaceutical Industries (9.05%), Divi's Laboratories (57.03%), Torrent Pharmaceuticals (35.32%). From a 5 year perspective, Cipla has underperformed peers relative to Sun Pharmaceutical Industries (16.46%) and Divi's Laboratories (12.03%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,373.19 | 1,365.62 |
| 10 | 1,378.74 | 1,373.46 |
| 20 | 1,377.37 | 1,382.6 |
| 50 | 1,414.39 | 1,398.86 |
| 100 | 1,412.56 | 1,399.53 |
| 200 | 1,380.48 | 1,406.34 |
Source: Dion Global
In the latest quarter, Cipla remained same as its previous close in promoter holding, while DII stake increased to 34.63%, FII holding fell to 20.20%, and public shareholding moved down to 15.93% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 1,99,02,429 | 2.47 | 2,804.65 | |
| 1,43,51,629 | 1.37 | 2,022.43 | |
| 55,49,373 | 1.3 | 782.02 | |
| 47,56,637 | 2.11 | 670.31 | |
| 47,33,207 | 2.37 | 667 | |
| 40,95,054 | 6.09 | 577.08 | |
| 40,86,211 | 1.06 | 575.83 | |
| 38,36,985 | 1.14 | 540.71 | |
| 35,00,000 | 0.87 | 493.22 | |
| 28,57,946 | 5.76 | 402.74 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Sep 29, 2026, 12:45 AM IST IST | Cipla - Board Meeting Intimation for The Quarter And Half Year Ended 30Th September, 2026 Under SEBI (Listing Obligations And |
| Sep 25, 2026, 12:38 AM IST IST | Cipla - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
| Sep 23, 2026, 04:26 AM IST IST | Cipla - Announcement under Regulation 30 (LODR)-Change in Management |
| Sep 18, 2026, 11:03 PM IST IST | Cipla - Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) R |
| Sep 04, 2026, 01:36 AM IST IST | Cipla - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Source: Dion Global
Cipla Ltd. is a Public Limited Listed company incorporated on 17/08/1935 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1935PLC002380 and registration number is 002380. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 18979.95 Cr. and Equity Capital is Rs. 161.56 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Cipla is ₹1,334.00 as on Oct 05, 2026.
The Cipla is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Cipla is ₹107,769.94 Cr as on Oct 05, 2026.
Today’s highest and lowest price of Cipla are ₹1,337.50 and ₹1,320.95.
The 52-week high/low is the highest and lowest price at which Cipla stock has traded in the past 52-week or nearly a year. The 52-week high of Cipla is ₹1,672.20 and 52-week low of Cipla is ₹1,165.55 as on Oct 05, 2026.
The Cipla has shown returns of -0.95% over the past day, -5.6% for the past month, -8.39% over 3 months, -11.98% over 1 year, 4.1% across 3 years, and 6.84% over 5 years.
P/E ratio of and PB ratio of Cipla are 31.97 and 3.06 on Oct 05, 2026. While the company gives a dividend yield of 0.97 per annum.
Source: Dion Global